Ontario is maintaining the remaining provincial masking requirements in select higher-risk indoor settings until June 11, 2022.
“To protect our progress in managing this latest wave, I am maintaining masking requirements in specific public settings where individuals who are, or may be, at increased risk of severe outcomes, are in close contact for extended periods of time,” said Dr. Kieran Moore, Chief Medical Officer of Health.
Provincial masking requirements which were set to expire on April 27, 2022 are being extended in current settings until 12:00 a.m. on June 11, 2022, including:
- public transit;
- health care settings (e.g., hospitals, doctors’ offices, clinics that provide health care services, laboratories, specimen collection centres, and home and community care);
- long-term care homes;
- retirement homes; and
- shelters and other congregate care settings that provide care and services to medically and socially vulnerable individuals.
A complete list of settings where masking requirements continue to apply is available online.
The province will start to receive supplies of Evusheld, an antibody treatment for immunocompromised individuals who are not positive for COVID-19 at the time of administration. Following two single-dose injections, the treatment provides protection from COVID-19 for six months.
Based on advice from the Canadian Agency for Drugs and Technologies in Health (CADTH), Evusheld will be available to individuals with the highest-risk of a severe outcome from COVID-19 in the coming weeks, including:
- solid organ transplant recipients;
- stem cell transplant recipients;
- CAR-T therapy recipients; and
- other hematologic cancer patients undergoing treatment.
“Thanks to the province’s high vaccination rates as well as an increase in antiviral treatment availability and eligibility, we have been able to cautiously and gradually reopen Ontario,” said Christine Elliott,
Evusheld was approved by Health Canada on April 14, 2022. The province is expecting to receive its first shipment in late April, with subsequent shipments expected in May and June.
Higher-risk groups are eligible to be tested and assessed for COVID-19 antiviral treatments, such as Paxlovid, in Ontario.
Eligible individuals can book their fourth dose appointment through the COVID-19 vaccination portal or by calling the Provincial Vaccine Contact Centre at 1-833-943-3900, directly through public health units that use their own booking systems, through Indigenous-led vaccination clinics, participating pharmacies and participating primary care settings at a recommended interval of five months after receiving their last booster.
Ontarians can access free rapid testing kits for at-home use. A list of participating retailers and more information on rapid tests for the general public can be found at Ontario.ca/rapidtest.
PCR testing is available for eligible individuals at over 200 assessment centres and community labs, and at over 790 participating pharmacies. Visit Ontario.ca/covidtestinglocations to find a testing location.
If you test positive on a PCR, rapid molecular or a rapid antigen test, you must isolate, except to seek testing and care. Visit Ontario.ca/exposed to learn more about isolation directions.